Immunotherapy for food allergies past, present, future

Clinical Reviews in Allergy and Immunology

Volumn 17, Issue 3, 1999, Pages 361-381

  Lehrer, Samuel B ^a   Wild, Laurianne G ^a   Bost, Kenneth L ^b   Sorensen, Ricardo U ^c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE;

DESENSITIZATION; DIET RESTRICTION; FATALITY; FOOD ALLERGY; HUMAN; IMMUNOTHERAPY; PROGNOSIS; REVIEW; TREATMENT PLANNING;

EID: 0032735069     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02737616     Document Type: Review

References (68)

1. 1. Yocum MW, Khan DA. Assessment of patients who have experienced anaphylaxis: A three year survey. Mayo Clin Proc 1994; 69:16-23.
2. 2. Ellis MH, Short JA, Heiner DC. Anaphylaxis after ingestion of a recently introduced hydrolyzed whey protein formula. J Pediatr 1991; 118:74-77.
3. 3. Saylor JD, Bahna SL. Anaphylaxis to casein hydrolysate formula. J Pediatr 1991; 118:71-74.
4. 4. Sampson HA, Mendelsoon IM, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992; 327:380-384.
5. 5. Yunginger JW, Sweeney KG, Sturner WQ, et al. Fatal food-induced anaphylaxis. JAMA 1988; 260:1450-1452.
6. 6. Bock SA. Natural history of severe reactions to foods in young children. J Pediatr 1985; 107:676-680.
7. 7. Bock SS. The natural history of food sensitivity. J Allergy Clin Immunol 1982; 69:173-177.
8. 8. Hill DJ, Cameron DJS, Francis DEM, et al. Challenge confirmation of late-onset reactions to extensively hydrolyzed formulas in infants with multiple food protein intolerance. J Allergy Clin Immunol 1995; 96:386-394.
9. 9. Metcalfe DD. Food allergy. In: Ogra PL, Lamm ME, McGhee JR, Mestecky J, Strober W, and Bienenstock J (eds.). Handbook of Mucosal Immunology, 1st ed. New York: Academic, 1994, pp. 493-504.
10. 10. Handbook of Mucosal Immunology, 2nd ed. Ogra P, Lamm M, McGhee J, Mestecky J, Stober W, & Bienenstock, eds), New York, Academic, 1998, in press.
11. 11. Neutra MR, Kraehenbuhl JM, et al. Cells as a pathway for antigen uptake and processing. In: Kagnoff, M, Kiyono, H (eds.). Essentials of Mucosal Immunology. New York: Academic, 1996, pp. 513-542.
12. 12. Kiyono H, McGee JR. T helper cells for mucosal immune responses. In: Handbook of Mucosal Immunology, 1st ed. Ogra P, Lamm M, McGhee J, Mestecky J, Strober W, & Bienenstock J (eds.). New York: Academic, 1994, pp. 263-274.
13. 13. Abreu-Martin MT, Targan SR. Lamina propria lymphocytes. In: Kagnoff, M, Kiyono, H (eds.). Essentials of Mucosal Immunology. New York: Academic, 1996, pp. 227-246.
14. 14. Lefrancois L. Basic aspects of intraepithelial lymphocyte immunobiology. In: Handbook of Mucosal Immunology, 1st ed. Ogra P, Lamm M, McGhee J, Mestecky J, Strober W, & J Bienenstock (eds.). New York: Academic, 1994, pp. 287-298.
15. 15. Noon L, Cantab B. Prophylactic inoculation against hay fever. Lancet 1911;i:1572.
16. 16a. Freeman J. "Rush" inoculation, with special reference to hay fever treatment. Lancet 1930; 1:744-747.
17. 16b. Nelson HS, Lahr J, Rule R, et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99:744-751.
18. 17. Oppenheimer JJ, Nelson HS, Bock SA, et al. Treatment of peanut allergy with rush immunotherapy. J. Allergy Clin Immunol 1992; 90:256-262.
19. 18. Tomasi TB. Oral tolerance. Transplantation 1980; 29(5):353-355.
20. 19. Taudorf E, Laursen LC, Lanner A, et al. Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol 1987; 80:153-161.
21. 20. Van Deusen MA, Angelini BL, Cordoro KM, et al. Efficacy and safety of oral immunotherapy with short ragweed extract. Ann Allergy Asthma Immunol 1997; 78:573-580.
22. 21. Machiels JJ, Somville MA, Jacquemin MG, et al. Allergen-antibody complexes can efficiently prevent seasonal allergic rhinitis and asthma in grass pollen hypersensitive patients. Allergy 1991; 46:335-348.
23. 22. Machiels JJ, Somville MA, Lebrun PM, et al. Allergic bronchial asthma due to dermatophygoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes. J Clin Invest 1990; 85:1024-1035.
24. 23. Briner TJ, Kuo MC, Keating KM, et al. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d 1. Proc Natl Acad Sci USA 1993; 90:7608-7612.
25. 24. Norman PS, Ohman JL Jr, Long AA, et al. Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 1996; 154:1623-1628.
26. 25. Casale TB, Bernstein IL, Busse WW, et al. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997; 100:110-121.
27. 26. Saban R. Human Fier1-IgG and humanized anti-IgE monoclonal antibody MaE11 block passive sensitizer of human and Rhesus monkey lung. Allergy Clin Immunol 1994; 94:836-843.
28. 27. Shields RL, et al. Inhibition of allergic reactions with antibodies to IgE. Int Arch Allergy Immunol 1995; 105:308-312.
29. 28. Boulet LP, Chapman KR, Cote J, et al. Inhibitory effects of an Anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997; 155:1835-1840.
30. 29. Fahy JV, Fleming HE, Wong HH, et al. The effect of an Anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997; 155:1828-1834.
31. 30. MacGlashan DW Jr, Bochner BS, Adelman DC, et al. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997; 158:1438-1445.
32. 31. Goodman JS, Van Uden JH, Kobayashi H, et al. DNA immunotherapeutics: New potential treatment modalities for allergic disease. Int Arch Allergy Immunol 1998; 116:177-187.
33. 32. Spiegelberg HL, Orozco EM, Roman M, et al. DNA Immunization: A novel approach to allergen-specific immunotherapy. Allergy 1997; 52:964-970.
34. 33. Slater JE, Zhang YJ, Arthur-Smith A, et al. A DNA vaccine inhibits IgE responses to the latex allergen Hev b 5 in mice. J Allergy Clin Immunol 1997; 99:S504.
35. 34. Reese G, Carle T, Lehrer SB. Epitope characterization of the major shrimp allergen Pen A 1 (Tropomyosin). J Invest Med 1998; 46(1):48A.
36. 35. Litwin A, Flanagan M, Entis G, et al. Immunologic effects of encapsulated short ragweed extract: A potent new agent for oral immunotherapy. Ann Allergy Asthma Immunol 1996; 77:132-138.
37. 36. Takahashi I, Kiyono H, Marinaro M, et al. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis 1996; 173:627-635.
38. 37. Clements JD, Chong C, Bost KL. Use of attenuated Salmonella vectors for oral vaccines. In: Kagnoff, M, Kiyono, H (eds.). Essentials of Mucosal Immunology. New York: Academic, 1996, pp. 513-542.
39. 38. Weiner HL. Oral tolerance for treatment of autoimmune disease. Ann Rev Med 1997; 48:341-351.
40. 39. Garside P, Mowat AM. Mechanisms of oral tolerance. Crit Rev Immunol 1997; 17:119-137.
41. 40. King HC, King WP. Alternatives in the diagnosis and treatment of food allergies. Otolaryngol Clin North Am 1998; 31:141-156.
42. 41. Cleland JL. Protein delivery from biodegradable microspheres. Pharm Biotechnol 1997; 10:1-43.
43. 42. Astwood JD, Fuchs RL. Allergenicity of foods derived from transgenic plants. In: Wuthrich, B, Ortolani, C (eds.). Highlights in Food Allergy. Monogr Allergy Basel: Karger 1996, Vol. 32, pp. 105-120.
44. 43. Harlander SK. Biotechnology - a means for improving our food supply. Food Technol 1991; 45(4):84.
45. 44. Kessler DA, Taylor MR, Maryanski Jr H, et al. The safety of foods developed by biotechnology. Science 1992; 256:1747.
46. 45. Olempska-Beer ZS, Kuznesof PM, DiNovi M, et al. Plant biotechnology and food safety. Food Technol 1993; 47(12):64.
47. 46. Matsuda T, Alvarez AM, Tada Y, et al. Gene engineering for hypo-allergenic rice: Repression of allergenic protein synthesis in seeds of transgenic rice plants by antisense RNA. In: Proceedings of the International Workshop on Life Science in Production and Food-consumption of Agricultural Products Session-4. Tsukuba Japan: Tsukuba Center, 1993.
48. 47. Matsuda T, Nakamura R. Molecular structure and immunologic properties of food allergens. Trends Food Sci Technol 1993; 4:289-293.
49. 48. Stanley JS, King N, Burks AW, et al. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch Biochem Biophys 1997; 342(2):244-253.
50. 49. Astwood JD, Fuchs RL, Lavrik PB, et al. Food biotechnology and genetic engineering. In: Metcalfe, DD, Sampson, HA, Simon, RA (eds.). Food Allergy: Adverse Reactions to Foods and Food Additives. Cambridge, MA, Blackwell Science, 1997, pp. 65-92.
51. 50. Businco L, Dreborg S, Einarsson R, et al. Hydrolysed cow's milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position paper. Pediatr Allergy Immunol 1993; 4:101-111.
52. 51. Watanabe M. Hypoallergenic rice as a physiologically functional food. Trends Food Sci Technol 1993; 4:125-128.
53. 52. Ayuso R, Reese G, Tanaka L, Ibanez MD, et al. IgE antibody response to raw and cooked meats proteins in suspected meat-sensitive patients. J Invest Med 1998; 46(1):49A.
54. 53. Lehrer SB, Reese G. Food allergens: Implications for biotechnology. In: Biotechnology and Safety Assessment, 2nd ed., in press.
55. 54. Adachi T, Izumi H, Yamada T, et al. Gene structure and expression of rice seed allergenic proteins belonging to the α-amylase/trypsin inhibitor family. Plant Mol Biol 1993; 21:239-248.
56. 55a. Lehrer SB, Taylor S, Hefle S, et al. Food allergens. In: Kay AB (ed.). Allergy and Allergic Diseases. London, UK: Blackwell Scientific Publications, 1997, pp. 961-980.
57. 55b. Burks AW, Shin D, Cockrell G, et al. Mapping and mutational analysis of the IgE binding epitopes on Ara h 1, a legume vicilin protein and a major allergen in peanut hypersensitivity. Eur J Biol 1997; 245:334-339.
58. 56. Elsayed S, Apold J, Holen E, et al. The structural requirements of epitopes with IgE binding capacity demonstrated by three major allergens from fih, egg and stree pollen. Scand J Clin Lab Invest Supp., 204, 17, 1991.
59. 57. Shanti KN, Martin BM, Nagpal S, et al. Identification of tropomyosin as the major shrimp allergen and characterization of its IgE binding epitopes. J Immunol 1993; 151:5354-5363.
60. 58. Johnson G, Elsayed S. Antigenic and allergenic determinants of ovalbumin. III. MHC la-binding peptide (OA 323-229) interacts with human and rabbit specific antibodies. Mol Immunol 1990; 27:821-827.
61. 59. Leung PSC, Chu KH, Chaw WK, et al. Cloning, expression, and primary structure of Metapenaeus enis tropomyosin, the major heat stable shrimp allergen. J Allergy Clin Immunol 1994; 92:837-845.
62. 60. Burks AW, Williams LW, Connaughton C, et al. Identification and characterization of a second major peanut allergen, Ara h II with use of the sera of patients with atopic dermatitis and positive peanut challenge. J Allergy Clin Immunol 1992; 900:962-969.
63. 61. Burks AW, Williams LW, Helm RM, et al. Identification of a major peanut allergen, Ara h I, in patients with topic dermatitis and positive peanut challenges. J Allergy Clin Immunol 1991; 88:172-179.
64. 62. Burks AW, King M, Sampson H, et al. Modification of a major peanut allergen leads to loss of IgE binding. Int Arch Allergy (Abstract), 1998.
65. 63a. Daul CB, Slattery M, Reese G, et al. Identification of the major brown shrimp (Penaeus aztecus) as the muscle protein tropomyosin. Int Arch Allergy Clin Immunol 1994; 105:49-55.
66. 63b. Reese G, Ayuso R, Carle T, et al. IgE binding epitopes of shrimp tropomyosin, the major allergen Pen a 1. Int Arch Allergy Clin Immunol, in press.
67. 64. Alderson MR, Armitage RJ, Tough TW, et al. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993;178.
68. 65. Constant SL, Bottomly K. Induction of TH1 and TH2 CD4+ t cell responses: Alternative approaches. Annu Rev Immunol 1997; 15:297-322.